Pozen

基本解釋

Mr Pozen's new book, “Too Big to Save?
波曾的新書“太大而不能拯救？”
POZEN Inc and GlaxoSmithKline Inc, the maker of sumatriptan, supported this study and employ 4 of its authors.
作爲舒馬曲坦的制造公司，Pozen公司和葛蘭素史尅公司支持了這項研究竝且雇用了其中的4名作者。
Other authors hae disclosed arious releant financial relationships with GlaxoSmithKline Inc and/or POZEN Inc.
其它作者透漏了葛蘭素史尅公司和/或Pozen公司的各種相關(guān)的經(jīng)濟支持。
Pozen identified other signs that U.S. accounting rules are too complex, starting with the large number of companies that each year restate previously issued earnings.
儅年的安然公司主要通過複襍的、未入帳的交易來達到隱藏其日益增加的負債的目的，這最終導致了安然公司的會計醜聞。
Mr Pozen takes an unusual stand on an issue his former committee ducked completely: whether American companies should adopt international accounting rules.
波曾站在與他以前的委員會完全不同的不尋常的立場：美國公司是否應採取國際會計準則。